Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
by La Jolla Institute for ImmunologyT cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-Co
Updated on: April 20,2024
20

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
by La Jolla Institute for ImmunologyT cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-Co
Updated on:April 20,2024
20
